Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | ALM201 |
Synonyms | |
Therapy Description |
ALM201 is a peptide therapy that is based on the human anti-angiogenic protein FKPB-L, which may decrease tumor cell migration and invasion and reduce formation of new vessels (Ann Oncol 2017, Vol 28, Suppl 5, Abstract #383P, PMID: 31772325). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ALM201 | ALM201 is a peptide therapy that is based on the human anti-angiogenic protein FKPB-L, which may decrease tumor cell migration and invasion and reduce formation of new vessels (Ann Oncol 2017, Vol 28, Suppl 5, Abstract #383P, PMID: 31772325). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|